Skip to main content
. 2021 Feb 10;16(3):683–688. doi: 10.1177/1932296821991136

Table 1.

Demographics and Clinical Characteristics.

Variable Overall (N = 432) CSII (N = 216) MDI (N = 216) p-value
Age, years 63 (53-70) 63 (53-70) 63 (53-70) 1.000
Sex, n (%) 0.554
 Male 263 (60.9) 135 (62.5) 128 (59.3)
 Female 169 (39.1) 81 (37.5) 88 (40.7)
Diabetes type, n (%) <0.0001
 Type1 120 (28.2) 100 (47.6) 20 (9.3)
 Type2 305 (71.8) 110 (52.4) 195 (90.7)
Endocrinology Consult, n (%) 255 (59.0) 216 (100) 39 (18.1) <0.0001
Admitting Services, n (%) 0.025
 Medicine 305 (70.6) 139 (64.3) 166 (76.9)
 Surgery 100 (23.1) 60 (27.8) 40 (18.5)
 Obstetrics 10 (2.3) 8 (3.7) 2 (0.9)
 Neurology 15 (3.5) 8 (3.7) 7 (3.2)
 Pediatrics 2 (0.5) 1 (0.5) 1 (0.5)
ICU admission 10 (2.3) 6 (2.8) 4 (1.8) 0.751
Steroid use, n (%) 16 (7.6) 11 (5.1) 0.324
Hemoglobin A1c [%] 7.6 (6.7-8.9) 7.6 (6.8-8.3) 7.6 (6.6-9.7) 0.384
Creatinine on admission, mg/dL 1.3 (0.9-2.7) 1.1 (0.8-2.3) 1.5 (1.0-3.1) <0.001
Admission blood glucose, mg/dL 182 (129-272) 176 (129-229) 192 (129-307) 0.035
Total number of glucose values over 24 hours 7 (5-10) 6 (4-9) 8 (5-11) <0.001
Average blood glucose over 24 hours, mg/dL 172 (136-214) 165 (134-195) 178 (139-234) 0.009

p-values are from Wilcoxon rank-sum test for continuous variables and Fisher’s exact test for categorical variables.

Values are listed as median [interquartile range] unless otherwise specified.

BG = blood glucose; CSII = continuous subcutaneous insulin infusion; DM = diabetes mellitus; MDI, multiple daily injections.